Clinical Trials List
Protocol NumberV220141117
Not yet recruiting
2015-07-01 - 2016-12-31
Phase II
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Ming-Shiang Wu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
72 participants
-
Global
72 participants
